MedPath

APO-IMIQUIMOD

APO-IMIQUIMOD

Dormant
DIN Number

02407825

Drug Class

Human

Market Date

Dec 31, 2013

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02407825
AIG Number0135820001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06BB10 IMIQUIMOD
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IMIQUIMODActive
Strength: 5 % / W/W
Monograph: IMIQUIMOD

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.